Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.03
-
NAV
₹9.70
-
Fund Started
21 Aug 2024
-
Fund Size
₹16.00 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
1 Year
7.10%
-
3 Year
-
-
5 Year
-
-
Equity
100.01%
-
Cash
-0.01%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 14.45% |
Dr. Reddy's Laboratories Ltd. | 5.82% |
Apollo Hospitals Enterprise Ltd. | 5.78% |
Divi's Laboratories Ltd. | 5.77% |
Max Healthcare Institute Ltd. | 5.42% |
Cipla Ltd. | 5.27% |
Lupin Ltd. | 4.27% |
Torrent Pharmaceuticals Ltd. | 3.26% |
Fortis Healthcare Ltd. | 3.15% |
Laurus Labs Ltd. | 2.94% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
-
Launch Date
21 Aug 2024
-
